Gliclazide Tablets

This product is a second-generation sulfonylurea hypoglycemic drug with a strong effect. Its mechanism is to selectively act on pancreatic β cells, promote insulin secretion, and increase the level of glucose after eating glucose, so that the production and output of glycogen are inhibited. Animal experiments and clinical use have shown that this product can reduce platelet aggregation and adhesion, and help prevent and treat diabetic microangiopathy.

The main ingredient is: Gliclazide. Its chemical name is: 1-(3-azabicyclo[3.3.0]octyl)-3-p-toluenesulfonylurea.

This product is white tablets.

Used for type 2 diabetes.

It should be taken under the guidance of a physician, with an initial oral dose of 40-80 mg, 1-2 times a day, and then adjusted to 80-240 mg a day, divided into 2-3 doses, based on blood and urine sugar levels. After blood and urine sugar levels are controlled, the daily maintenance dose can be changed. Elderly patients should reduce the dose as appropriate.

Occasionally, there may be mild nausea, vomiting, upper abdominal pain, constipation, diarrhea, erythema, urticaria, thrombocytopenia, granulocytopenia, anemia, etc. Most of them disappear after stopping the drug.

1. Patients with impaired liver and kidney function are contraindicated. 2. Patients allergic to sulfonylureas are contraindicated.

Precautions for children: Not clear yet. Precautions for pregnancy and lactation: Animal experiments and clinical observations have shown that sulfonylurea hypoglycemic drugs can cause teratogenesis and are excreted through breast milk, so pregnant women and nursing mothers should not use them. Precautions for the elderly: The dosage should be appropriately reduced.

When used in combination with non-steroidal anti-inflammatory drugs (especially salicylates), sulfonamide antibiotics, coumarin anticoagulants, monoamine oxidase inhibitors, beta-receptor blockers, benzodiazepines, tetracycline, chloramphenicol, dicyclohexine, clofibrate, ethanol and other drugs, the dosage should be reduced to avoid hypoglycemia.

Keep away from light and store in a sealed container.

80mg

24 months

Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY

• Founded in:

  1994-05-19

• Address:

  No. 388, Hahei Highway, Hulan District (production base No. 109, Xuefu Road, Nangang District, No. 1, Junmin Street, Xiangfang District)

• Tax NO.:

  912301008280277137

• Registered Funds:

  -

• Website:

  Log in to view

• Email:

  Log in to view